XML 84 R19.htm IDEA: XBRL DOCUMENT v3.19.3
Note M - Share-based Compensation
6 Months Ended
Sep. 29, 2019
Notes to Financial Statements  
Share-based Payment Arrangement [Text Block]
NOTE M– SHARE-BASED COMPENSATION
 
Total share-based compensation during the
thirteen
-week periods ended
September 29, 2019
and
September 23, 2018
was
$30,000
and
$23,000,
respectively. Total share-based compensation during the
twenty-six
week periods ended
September 29, 2019
and
September 23, 2018
was
$58,000
and
$104,000,
respectively.
Total share-based compensation is included in general and administrative expenses in our accompanying Consolidated Statements of Earnings. As of
September 29, 2019,
there was
$226,000
of unamortized compensation expense related to share-based incentive awards. We expect to recognize this expense over approximately
twenty-three
months, which represents the weighted average remaining requisite service periods for such awards.
 
The Company recognizes compensation cost for unvested stock-based incentive awards on a straight-line basis over the requisite service period. Compensation cost charged to expense under all stock-based incentive awards is as follows (in thousands):
 
     Thirteen weeks ended       Twenty-six weeks ended  
   
Sept. 2
9
, 201
9
   
Sept. 23, 2018
   
Sept. 2
9
, 201
9
   
Sept. 23, 2018
 
                                 
Stock options
 
$
22
    $
22
   
$
43
    $
60
 
Restricted stock
 
 
8
     
1
   
 
15
     
44
 
Total compensation cost
 
$
30
    $
23
   
$
58
    $
104
 
 
Stock options:
 
 
There were
no
new share-based awards granted during the
twenty-six
week period
September 29, 2019.
 
During the fiscal year
March 31, 2019,
the Company granted options to purchase
10,000
shares at an exercise price of
$89.90
per share, all of which expire
five
years from the date of grant. All such stock options vest ratably over a
three
-year period commencing
September 12, 2019.
 
Transactions with respect to stock options for the
twenty-six
weeks ended
September 29, 2019
are as follows:
 
           
Weighted-
   
Weighted-
   
Aggregate
 
           
Average
   
Average
   
Intrinsic
 
           
Exercise
   
Remaining
   
Value
 
   
Shares
   
Price
   
Contractual Life
   
(in thousands)
 
                                 
Options outstanding at March 31, 2019 fiscal year (A)
   
42,234
    $
46.807
     
1.32
    $
1,127
 
Granted
   
-
     
-
     
-
     
-
 
Exercised
   
(32,234
)  
$
33.438
     
-
     
1,134
 
Options outstanding at September 29, 2019
 
 
10,000
   
$
89.90
   
 
3.95
     
-
 
                                 
Options exercisable at September 29, 2019
 
 
3,333
   
$
89.90
   
 
3.95
   
 
-
 
 
 
A-
Represents outstanding options after giving effect to the replacement options issued in connection with the Company’s special dividend to shareholders of record on
December 22, 2017.
 
Restricted stock:
 
 
Transactions with respect to restricted stock for the
twenty-six
weeks ended
September 29, 2019
are as follows:
 
   
 
 
 
 
Weighted-
 
   
 
 
 
 
Average
 
   
 
 
 
 
Grant-date
Fair value
 
   
Shares
   
Per share
 
Unvested restricted stock at March 31, 2019
 
 
1,000
   
$
89.90
 
Granted
 
 
-
   
 
-
 
Vested
 
 
(333
)
 
$
89.90
 
Unvested restricted stock at September 29, 2019
 
 
667
   
$
89.90